Understanding the Cardiovascular Profile: Does Belsomra Prolong QTc?
•
4 min read
According to the U.S. Food and Drug Administration (FDA), clinical trials found that Belsomra (suvorexant) does not prolong the QTc interval to any clinically relevant extent. Concerns over the cardiac safety of medications are common, and for Belsomra, a drug prescribed for insomnia, understanding its effect on the heart's electrical activity is crucial for patients and healthcare providers.
